Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
02/28/2007 | EP1501795B1 Cinnamic acid amides |
02/28/2007 | EP1492771B1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
02/28/2007 | EP1458703B1 Isochroman compounds for treatment of cns disorders |
02/28/2007 | EP1441734B1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
02/28/2007 | EP1397350B1 Isoquinolinone derivatives as parp inhibitors |
02/28/2007 | EP1370531B1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
02/28/2007 | EP1049674B1 Method for producing (-)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-piperidine |
02/28/2007 | CN1922174A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
02/28/2007 | CN1922170A Novel hydroxy-6-heroarylphenanthridines and their use as pde4 inhibitors |
02/28/2007 | CN1922160A Compounds |
02/28/2007 | CN1922144A Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
02/28/2007 | CN1922141A Novel heterocyclic compound |
02/28/2007 | CN1922139A Bicyclic amide derivatives |
02/28/2007 | CN1922135A 免疫抑制剂化合物和组合物 Immunosuppressant compounds and compositions |
02/28/2007 | CN1301975C 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
02/27/2007 | US7183415 Melanin-concentrating hormone antagonistic action for treating obesity, for example 4'-fluoro-N-[8-methyl-3-(1-pyrrolidinylmethyl)-7-quinolinyl][1,1'-biphenyl]-4-carboxamide |
02/27/2007 | US7183414 Processes for the preparation of benzoimidazole derivatives |
02/27/2007 | US7183408 calcium atorvastatin (Lipitor) intermediate; from claimed intermediate 5-(4-fluorophenyl)-2-isopropyl-1-(3-morpholin-4-yl-3-oxo-propyl)-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide; via diol esters from the 1,3,5-tricarbonyl precursors in a stereoselective ruthenium-catalyzed hydrogenation |
02/27/2007 | US7183405 Labeling oligonucleotides comprising providing a solid support-bound oligonucleotide, an amino group comprised of bifunctional linker arm and an activated label, react support-bound oligonucleotide with bifunctional linker arm, react support with label, recover labeled, support-bound protected oligomer |
02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
02/27/2007 | US7183312 Compounds for use as antigrowth agents or antitumor agents and with solvents |
02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
02/27/2007 | US7183291 Method for the treatment of malaria by the use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4- (6-methoxy-8-quinolinyl)-1,4-pentanediamine as gametocytocidal agent |
02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
02/27/2007 | US7183287 Substituted pyrimidinones |
02/27/2007 | US7183286 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
02/27/2007 | US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
02/27/2007 | US7183278 (Halo)alkoxy-3-(alkoxy or alkanoyl)-N-alkylene picolinamide; reacting a picolinic acid, ester or acyl halide with a primary amine; agricultural fungicides; rice blast, cucumber anthracnose, powdery mildew of cucumber and wheat leaf rust |
02/27/2007 | US7183273 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor |
02/27/2007 | US7183270 Cyclic derivatives as modulators of chemokine receptor activity |
02/22/2007 | WO2007020936A1 Bicyclo heterocyclic compound having antifungal action |
02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
02/22/2007 | WO2007020426A1 Pyrazolone derivatives for the treatment of tuberculosis |
02/22/2007 | WO2007020194A1 Piperidine and piperazine derivatives as p2x3 antagonists |
02/22/2007 | WO2007020046A1 Benzoquinazoline derivatives and their use in treating bone disorders |
02/22/2007 | WO2006134163A8 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
02/22/2007 | WO2006127379A3 Par2-modulating compounds and their use |
02/22/2007 | WO2006084186A3 Compounds comprising linked hetero aryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
02/22/2007 | US20070043221 exemplified by Pyrrole Ester O-benzyl lactol methyl acetal |
02/22/2007 | US20070043080 Substituted anilinic piperidines as MCH selective antagonists |
02/22/2007 | US20070043065 Amide derivatives |
02/22/2007 | US20070043051 Methods and compositions of novel triazine compounds |
02/22/2007 | US20070043045 Novel high affinity thiophene-based and furan-based kinase ligands |
02/22/2007 | US20070043040 Inhibitors of akt (protein kinase b) |
02/22/2007 | US20070043037 Pyrimidine derivatives as orexin receptor antagonists |
02/22/2007 | US20070043015 Phenyl pyrrolidine ether tachykinin receptor antagonists |
02/22/2007 | US20070043010 Quinazoline derivatives |
02/22/2007 | US20070043009 Quinazoline derivatives as tyrosine kinase inhibitors |
02/22/2007 | US20070042973 Treatment of pain and fever |
02/22/2007 | CA2750864A1 Bis-aryl amide compounds and methods of use |
02/22/2007 | CA2619706A1 Novel high affinity quinoline-based kinase ligands |
02/22/2007 | CA2619262A1 Pyrazolone derivatives for the treatment of tuberculosis |
02/22/2007 | CA2619249A1 Benzoquinazoline derivatives and their use in treating bone disorders |
02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
02/22/2007 | CA2618340A1 Piperidine and piperazine derivatives as p2x3 antagonists |
02/21/2007 | EP1754739A1 Deuterated polyimides and derivatives thereof |
02/21/2007 | EP1754710A2 2'-Fluoroncucleosides |
02/21/2007 | EP1754704A1 Diamidine compounds as DNA minor groove binders |
02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
02/21/2007 | EP1753745A2 Pyrazinylmethyl lactam derivatives |
02/21/2007 | EP1753731A2 Pyrimidin-4-one derivatives and their use as p38 kinase modulators |
02/21/2007 | EP1753725A1 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics |
02/21/2007 | EP1753721A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
02/21/2007 | EP1753719A1 Substituted pyrrolidine-2-ones |
02/21/2007 | EP1753718A1 3-amino-2-phenylpyrrolidine derivatives |
02/21/2007 | EP1581517B1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
02/21/2007 | EP1567488B1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
02/21/2007 | EP1511727B1 Aromatic sulfones and their medical use |
02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
02/21/2007 | EP1135374B9 Benzimidazole compounds that are vitronectin receptor antagonists |
02/21/2007 | EP1000025B1 Substituted naphthopyrans |
02/21/2007 | EP0968193B1 Phenylsulphonyl ureas, processes for their preparation and their use as herbicides and plant-growth regulators |
02/21/2007 | CN1918151A Tricyclic steroid hormone nuclear receptor modulators |
02/21/2007 | CN1918150A Process for preparing substituted benzopyran compounds |
02/21/2007 | CN1918149A Novel chelating agents and highly luminescent and stable chelates and their use |
02/21/2007 | CN1918147A 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
02/21/2007 | CN1918146A Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
02/21/2007 | CN1918145A Amino heterocyclic modulators of chemokine receptor activity |
02/21/2007 | CN1918141A Aminodibenzodioxin derivative and organic electroluminescent device using same |
02/21/2007 | CN1918131A Novel inhibitors of glutaminyl cyclase |
02/21/2007 | CN1918129A Therapeutic agent |
02/21/2007 | CN1918119A Bicycloester derivative |
02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
02/21/2007 | CN1917880A Pyrimidines with tie2 (tek) activity |
02/21/2007 | CN1917879A Pyrimidines with tie2 (tek) activity |
02/20/2007 | US7179922 Chemical compounds |
02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
02/20/2007 | US7179912 Materials and methods to potentiate cancer treatment |
02/20/2007 | US7179907 3-amino-2-oxo-azetidin-1-yl) acetic acid derivatives with anti-PBP2a activity; providing a monobactam core alkyne,reacting monobactam alkyne under conditions that promote cyclotrimerization, performing a Diels-Alder reaction between the cyclotrimerization product of b) and a diene reactant |
02/20/2007 | US7179896 Method of making PNA oligomers |
02/20/2007 | US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
02/20/2007 | US7179825 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
02/20/2007 | US7179822 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
02/20/2007 | US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
02/20/2007 | US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |